The Bulletin
The Times


.

Alterity Therapeutics Announces New US Patent to Expand its Portfolio of Compounds for Neurodegenerative Diseases including Alzheimer's and Parkinson's

  • Written by PR Newswire

Composition of Matter Patent Covers More than 80 Novel Compounds

Alterity Therapeutics Announces New US Patent to Expand its Portfolio of Compounds for Neurodegenerative Diseases including Alzheimer's and Parkinson's

MELBOURNE, Australia, Aug. 4, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced the United States Patent...

hacklink esim balkanzlibraryzlibrarySahabetuk casinos not on gamstopGamStopgrandpashabet girişjojobetviagra 100 mg fiyat